COMPUTE & CONNECTIVITY DESK · DISPATCH
The U.S. Department of Commerce signed a final research-and-development award of up to US$1 billion to Anderon LLC on 16 September 2026 under the CHIPS and Science Act. Anderon is IBM's newly formed subsidiary, a 300-millimeter pure-play quantum wafer foundry headquartered in Albany, New York, and the signing converts the letter of intent the department announced with IBM on 21 May 2026 into a definitive agreement. The instrument is a grant. "Up to" is the department's own phrasing, and a ceiling is not a payment: what was signed is an obligation to fund against terms, not a transfer on the day.
A second billion sits next to it and must stay there. IBM's release describes the foundry as backed by an additional US$1 billion investment from the parent, specified in May as cash into Anderon alongside intellectual property, assets and a workforce. That is private capital committed by a corporation to its own venture. Much of the coverage adds the two into a US$2 billion figure; a federal grant and a parent's equity injection are different objects with different owners, and they are not added here.
What the state is funding is capacity, not a laboratory. Anderon fabricates wafers for superconducting qubit arrays, quantum input/output signaling and readout signal chains, and the company says the first quantum wafers are already running through the facility—early production, on its own account, not installed volume. As a pure-play foundry it is structured to fabricate for vendors other than IBM. That places the award one layer beneath the three machine makers whose US$100 million awards the department finalized on 8 September: those funded the firms that build systems; this funds the wafer source they would draw on. The department has now committed capital at both tiers of the domestic quantum stack, in separate instruments, and the foundry line is the largest single item in the May letters.
Then there is what the record does not say. When D-Wave Quantum, Rigetti Computing and Quantinuum announced their finalizations on 8 September, each named a minority, non-controlling equity stake for the department as a condition of the award. The department's release on Anderon runs to a paragraph and names no such condition; IBM's, considerably longer, does not either. Trade coverage the next day carried the condition as portfolio-wide, without a source specific to Anderon. Whether the largest award in the program carries the term the smaller ones disclosed cannot be settled from what the two parties published. That both chose not to say is the documented fact, and for a wholly owned subsidiary a conspicuous one.
The sovereign thread needs no inference. This is a federal appropriation, signed by the department as counterparty, placed into a private foundry whose parent is matching it—capital statecraft proper, buying not direction over IBM's roadmap but the existence, on American soil, of a wafer source the whole modality can use. The machine makers got the headlines, and one of them published its covenants. The foundry beneath them got the largest check and the shortest release—and in a program that has made the state's shareholding its signature, the term left unsaid is the one to keep asking about.
— Capital Statecraft Intelligence · Compute & Connectivity Desk
Primary source(s): IBM Newsroom press release, 16 September 2026 ("Anderon, an IBM Company, Finalizes Agreement with the U.S. Department of Commerce for a $1 Billion CHIPS Award…") (primary); NIST/U.S. Department of Commerce release, 16 September 2026 ("Department of Commerce Announces Finalization of CHIPS R&D Award with Anderon") (primary); IBM Newsroom press release, 21 May 2026 ("IBM and U.S. Department of Commerce Announce America's First Purpose-Built Quantum Foundry, Supported by Proposed $1 Billion CHIPS Award") (primary, for the letter-of-intent stage)